Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27690634)
Watch
English
Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
review article
3 references
stated in
Europe PubMed Central
stated in
PubMed
retrieved
8 February 2021
stated in
PubMed
retrieved
23 October 2022
title
Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics
(English)
1 reference
stated in
PubMed
main subject
phase I clinical trial
0 references
oncolytic virus
1 reference
based on heuristic
inferred from title
neoplasm
1 reference
stated in
PubMed
retrieved
8 February 2021
Reovirus
1 reference
based on heuristic
inferred from title
author name string
Harrington KJ
series ordinal
1
1 reference
stated in
PubMed
Vile RG
series ordinal
2
1 reference
stated in
PubMed
Melcher A
series ordinal
3
1 reference
stated in
PubMed
Chester J
series ordinal
4
1 reference
stated in
PubMed
Pandha HS
series ordinal
5
1 reference
stated in
PubMed
language of work or name
English
0 references
publication date
2010
1 reference
stated in
PubMed
12 March 2010
2 references
stated in
PubMed Central
retrieved
8 February 2021
stated in
PubMed Central
retrieved
23 October 2022
published in
Cytokine and Growth Factor Reviews
3 references
stated in
PubMed
stated in
PubMed Central
retrieved
8 February 2021
stated in
PubMed Central
retrieved
23 October 2022
volume
21
1 reference
stated in
PubMed
issue
2-3
1 reference
stated in
PubMed
page(s)
91-8
1 reference
stated in
PubMed
cites work
Intelligent design: combination therapy with oncolytic viruses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
20 March 2017
The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
20 March 2017
Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbits
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
20 March 2017
Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
20 March 2017
Continuous cultures of fused cells secreting antibody of predefined specificity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
7 April 2017
Ionizing radiation-induced adenovirus infection is mediated by Dynamin 2
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
20 March 2017
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
7 April 2017
ras oncogenes in human cancer: a review
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
7 April 2017
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
7 April 2017
Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
HPMA copolymers for masking and retargeting of therapeutic viruses.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Synergistic effects of oncolytic reovirus and cisplatin chemotherapy in murine malignant melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Cell carriers for oncolytic viruses: Fed Ex for cancer therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Virus combinations and chemotherapy for the treatment of human cancers.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Exploiting synergies between radiation and oncolytic viruses.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
A strategy for genetic modification of the spike-encoding segment of human reovirus T3D for reovirus targeting.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Reovirus: viral therapy for cancer 'as nature intended'.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Genetically targeted cancer therapy: tumor destruction by PKR activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Observations on a newly recognized virus (Abney) of the reovirus family
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Ionizing radiation increases adenovirus uptake and improves transgene expression in intrahepatic colon cancer xenografts
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Reovirus therapy of tumors with activated Ras pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
The v-erbB oncogene confers enhanced cellular susceptibility to reovirus infection.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Recent developments in radioimmunotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Protamine precipitation of two reovirus particle types from polluted waters.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Evaluation of cell lines and immunofluorescence and plaque assay procedures for quantifying reoviruses in sewage
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
IgM antibodies induce the production of antibodies of the same specificity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
A phase-I study of repeated therapy with radiolabelled antibody to carcinoembryonic antigen using intermittent or continuous administration of cyclosporin A to suppress the immune response
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
The preferential cytotoxicity of reovirus for certain transformed cell lines
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
29 September 2017
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
2 June 2018
A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
27 November 2018
Cyclophosphamide allows for in vivo dose reduction of a potent oncolytic virus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
27 November 2018
Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
27 November 2018
Prevalence of Reovirus‐Specific Antibodies in Young Children in Nashville, Tennessee
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
27 November 2018
Reovirus infections in human volunteers.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
27 November 2018
Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3915505
retrieved
27 November 2018
Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/20223697
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1016/J.CYTOGFR.2010.02.006
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
103648
OpenCitations bibliographic resource ID
103648
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
103648
PMCID
3915505
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
103648
PubMed ID
20223697
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
103648
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
